Novartis

Member

Novartis Sustainability Profile

Novartis is not currently tracking sustainability.

Novartis is committed to comprehensive ESG reporting and transparency across environmental, social, and governance topics. The company aims to improve its environmental footprint to mitigate climate change impacts on the planet and human health through efficient resource use and greenhouse gas emissions reduction.

About Novartis

  • Status
  • Unverified

Novartis Sustainability Actions

Created ESG Reporting Council

Novartis created an ESG Reporting Council to review the quality of ESG data, current trends and emerging standards.

COVID-19 Drug Availability Program

Novartis made 15 drugs that treat key symptoms of COVID-19 available to low-income and lower-middle-income countries at zero profit.

Novartis Sustainability Commitments

2025

Carbon Neutrality in Operations

Achieve carbon neutrality in own operations.

2030

Full Value Chain Carbon Neutrality

Achieve full carbon neutrality across the entire value chain.

2040

Net-Zero Emissions Target

Achieve net-zero emissions.


About Novartis

  • Status
  • Unverified

This information references https://www.novartis.com/ and was sourced on 19/07/2023. Is this your business? Suggest an edit

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.